OncoTartis, Inc.
PrivateLast Round
Series B
Dec 11, 2017
Total Funding Raised
$9.47M
Company Overview
OncoTartis, Inc. is a biotechnology company that develops a novel category of anti-cancer drugs directed against tissue-specific targets for a variety of malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoTartis, Inc. Comparables
Compare OncoTartis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Plan Therapeutics | 91% | |
| Alphina Therapeutics | 81% | |
| Theranib Inc. | 74% |
OncoTartis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 11, 2017 | ||||
| Grant | Dec 28, 2011 | ||||
| Series A | Feb 17, 2011 |
OncoTartis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skolkovo Foundation | Grant |
| Pharmstandard International S.A. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2011
$3.47M grant received from Skolkovo Foundation.
- Feb 17, 2011
Completed a Series A funding round.
OncoTartis, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoTartis, Inc.'s valuation, stock price, and market status.
Is OncoTartis, Inc. a public or private company?
OncoTartis, Inc. is a private company.
What is the current stock price of OncoTartis, Inc.?
OncoTartis, Inc. is a private company, so its shares have no public market price. Caplight tracks OncoTartis, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoTartis, Inc. worth (valuation)?
Valuation information for OncoTartis, Inc. is not publicly available.
Can I buy OncoTartis, Inc. stock?
OncoTartis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoTartis, Inc.'s last funding round?
OncoTartis, Inc.'s most recent funding round was Series B on December 11, 2017.
Who are the main investors in OncoTartis, Inc.?
Key investors in OncoTartis, Inc. include Skolkovo Foundation, Pharmstandard International S.A..
Will OncoTartis, Inc. IPO soon?
No public IPO plans have been announced for OncoTartis, Inc..
How can I track OncoTartis, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in OncoTartis, Inc.'s shares on secondary markets.